Risk of mortality associated with concomitant antidepressant and benzodiazepine therapy among patients with depression: a population-based cohort study

BACKGROUND: With antidepressants (ADs) having minimal therapeutic effects during the initial weeks of treatment, benzodiazepines (BZDs) are concomitantly used to alleviate depressive symptoms of insomnia or anxiety. However, with mortality risks associated with this concomitant use yet to be examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Han Eol, Jeon, Ha-Lim, Oh, In-Sun, Kim, Woo Jung, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724883/
https://www.ncbi.nlm.nih.gov/pubmed/33292197
http://dx.doi.org/10.1186/s12916-020-01854-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724883/
https://www.ncbi.nlm.nih.gov/pubmed/33292197
http://dx.doi.org/10.1186/s12916-020-01854-w

Ejemplares similares